An ongoing shortage of medications prescribed to treat attention-deficit/hyperactivity disorder or ADHD, such as Adderall, has left many patients struggling to get ...
Supply from drugmakers for the stimulant medications most commonly prescribed for ADHD are still falling short of demand, the Food and Drug Administration says, and many Americans who rely on these ...
While the representatives acknowledge that the agencies have made headway in the broader ADHD medicine shortage through efforts such as approving generics to Takeda’s Vyvanse and raising the ...
OMAHA, Neb. (WOWT) - Attention-deficit/hyperactivity disorder (ADHD) impacts millions of kids and adults. At Children’s Omaha, Psychiatry Division Chief Dr ...
The national ADHD medicine shortage, which has impacted access to generic versions of Adderall, Vyvanse, and Concerta, was first announced back in October 2022. Now, 16 months later, patients are ...
Attention deficit hyperactivity disorder, or ADHD, is a common neurodevelopmental disorder that can affect children and adults. It’s often diagnosed during childhood or adolescence — in fact, an ...
GREEN BAY, Wis. (WBAY) - Many people being treated for ADHD continue to struggle to fill prescriptions in our area. “It’s kind of a loaded question as far as the stimulant shortage goes. Not a day ...
Comer and McClain sent their initial request to the DEA in May, but they said the agency has largely not cooperated with the committee this summer. “In the three months since the initial request, DEA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results